Pemitini
Pemigatinib
- Concentración
- 4.5mg
- Fabricante
- TLPH Pharma
- Disponibilidad
- Disponible para obtener
Pemigatinib 4.5mg — Tablet, 42's Pot
¿Necesita ayuda?
Nuestro equipo de soporte multilingüe puede ayudarle con disponibilidad, envío y pedidos.
Chatear por WhatsApp
Escanear para WeChat
Sobre este medicamento
Originator: PEMAZYRE by INCYTE CORP · Manufacturer: TLPH Pharma. Indication & Dosage: Pemitini (Pemigatinib), generic PEMAZYRE is a prescription medicine used to treat of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma (Bile duct cancer) with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement. Pemigatinib is also used for the treatment of adults with relapsed or refractory myeloid/ lymphoid neoplasms (MLNs) with fibroblast rearrangement. Pemigatinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. Pemitini is manufactured by TLPH Pharma Ltd. In Laos. Pemigatinib has to be taken orally with or without food as directed by your doctor. Side Effects: The most common adverse reactions of Pemigatinib are: Weight loss , mouth sores , dry mouth , constipation , changes in taste, dry eyes, loss of appetite, nausea , vomiting , diarrhea , tiredness/weakness, headache, or dry skin. The above information comes from the Internet. Please consult with doctor for medical advice.
Indicaciones
Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.
